Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data
Ann Kinga Malinowski(Mount Sinai Hospital), Nadine Shehata(Mount Sinai Hospital), Patricia Palcu(University of Toronto), George Tomlinson(Toronto General Hospital), Kevin H.M. Kuo(University Health Network), Richard Ward(University of Tennessee Health Science Center)
Cited by 22
Related Papers
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
|The Lancet|2017|775
High Body Mass Index Is An Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C
|Hepatology|2003|359
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Online haemodiafiltration: definition, dose quantification and safety revisited
|Nephrology Dialysis Transplantation|2013|256